Evidence map›Paper›PMID 21789217›Full record

ArticlePloS one2011

Accelerating haplotype-based genome-wide association study using perfect phylogeny and phase-known reference data.

Yungang He, Cong Li, Christopher I Amos, Momiao Xiong, Hua Ling, Li Jin

Abstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. PhytoKeys · 2025
    Article
  2. Article
  3. Review
  4. Associations ofDisease markers · 2019
    Article
  5. Article
  6. Article
  7. Genetics of diabetes complications.Mammalian genome : official journal of the International Mammalian Genome Society · 2014
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yungang HeDepartment of Computational Genomics, CAS-MPG Partner Institute for Computational Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China. heyungang@gmail.com
Cong Li
Christopher I Amos
Momiao Xiong
Hua Ling
Li Jin

Funding

NARAC The Genetics of Rheumatoid ArthritisR01AR044422 · NIAMS · NORTH SHORE UNIVERSITY HOSPITAL · PI GREGERSEN, PETER K. · 1997 to 2011
$6.0M
Network Approach to GWA Studies of Rheumatoid Arthritis (RA), Ankylosing SpondyliR01AR057120 · NIAMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI XIONG, MOMIAO · 2009 to 2010
$554k
NIAMS NIH HHS AR44422NIAMS NIH HHS AR57120NIAMS NIH HHS R01 AR044422NIAMS NIH HHS R01 AR057120
6 · The paper itself

Abstract

The genome-wide association study (GWAS) has become a routine approach for mapping disease risk loci with the advent of large-scale genotyping technologies. Multi-allelic haplotype markers can provide superior power compared with single-SNP markers in mapping disease loci. However, the application of haplotype-based analysis to GWAS is usually bottlenecked by prohibitive time cost for haplotype inference, also known as phasing. In this study, we developed an efficient approach to haplotype-based analysis in GWAS. By using a reference panel, our method accelerated the phasing process and reduced the potential bias generated by unrealistic assumptions in phasing process. The haplotype-based approach delivers great power and no type I error inflation for association studies. With only a medium-size reference panel, phasing error in our method is comparable to the genotyping error afforded by commercial genotyping solutions.

Indexed as

PhylogenyComputer SimulationDatabases, GeneticGenetics, PopulationGenome-Wide Association StudyHaplotypesHumansPolymorphism, Single NucleotideReference StandardsReproducibility of Results

Identifiers

PMID21789217
PMCPMC3137625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.